stemmacolore
Cerca

Investigating the gut microbiome and circulating cytokines as biomarkers to predict efficacy and toxicity of immunotherapy in patients with triple negative breast cancer: a translational analysis of the prospective A-BRAVE randomized trial (MERLIN)

Investigating the gut microbiome and circulating cytokines as biomarkers to predict efficacy and toxicity of immunotherapy in patients with triple negative breast cancer: a translational analysis of the prospective A-BRAVE randomized trial (MERLIN)

Tipologia

Ricerca di base/clinica

Stato

aperto

Copertura

Nazionale

Ruolo dell'Istituto

Capofila

Ente finanziatore

IOV - IRCCS

Anno di finanziamento

2019

Unità Operativa

UOC Oncologia 2

Principal Investigator

Prof.ssa Valentina Guarneri
Torna in alto